Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 20/20 | 0.65 |
| ▸ | KCNH2 | Q12809 | 18/20 | 0.65 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.51 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29290977 | 0.89 | CNR1 (0.65) | CNR1KCNH2CYP1A1CYP2C8CYP2D6 | |
| SCHEMBL29290979 | 0.83 | CNR1 (0.52) | CNR1KCNH2CYP1A1CYP2C8CYP2D6 | |
| SCHEMBL29290974 | 0.82 | CNR1 (0.65) | CNR1KCNH2CYP1A1CYP2C8CYP2D6 | |
| SCHEMBL3564472 | 0.79 | CNR1 (1.00) | CNR1KCNH2CYP1A1CYP2C8CYP2D6 | |
| SCHEMBL29290978 | 0.74 | CNR1 (0.53) | CNR1KCNH2 | |
| SCHEMBL3574139 | 0.71 | CNR1 (1.00) | CNR1KCNH2CYP1A1CYP2C8CYP2D6 | |
| SCHEMBL13437706 | 0.68 | CNR1 (0.60) | CNR1KCNH2CYP1A1CYP2C8CYP2D6 | |
| SCHEMBL3566537 | 0.67 | CNR1 (1.00) | CNR1KCNH2CYP1A1CYP2C8CYP2D6 | |
| SCHEMBL29290973 | 0.65 | CNR1 (0.60) | CNR1KCNH2 | |
| SCHEMBL3570283 | 0.65 | CNR1 (0.82) | CNR1KCNH2CYP1A1CYP2C8CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109689045-A | Purposes of the topical formulations of cannboid in treatment epidermolysis bollosa and Related connective tissue illness | 因美制药公司 | 2019-04-26 | — | — | CN | claimed |
| CN-109689045-A | Purposes of the topical formulations of cannboid in treatment epidermolysis bollosa and Related connective tissue illness | 因美制药公司 | 2019-04-26 | — | — | CN | disclosed |